Menu

Explore COVID-19
Clinical Trials Data

By Enterprise for Society (E4S)
A Partnership between EPFL, UNIL and IMD

View the app
Cite us

Highlights of the application

Visualize COVID-19 trials by country and organization

768
COVID-19 Drugs in the World
44.6% progressed to the next phase,
from January 2020 to August 2020
China
is leading in COVID-19 research
contributing 15.5% of all
COVID-19 trials in the world
2257
Enterprises Involved
contributing 36.1% of all
COVID-19 trials in the world

COVID-19 Trials across the Globe

Key Insights

Locus of clinical research on COVID-19 is shifting from China to Europe and US
Switzerland is making a leading progress on COVID-19 clinical research
More clinical research on COVID-19 is coming from the non-commercial sector

Interactive Visualization of the Data


Total trials
Population
R&D spendings
Show % change

Sponsored by:

Enterprise for Society Center
Enterprise for Society Center

Data source:
Cite us: Conti A, Gaule P, Hrendash T. Explore COVID-19 Clinical Trials Data, http://www.web.site